Sara Beygi
About Sara Beygi
Sara Beygi serves as the Medical Director of Clinical Development at Kite Pharma, a position she has held since 2021. She has a background in hematology and oncology, having completed fellowships and research at prestigious institutions such as Stanford University and Thomas Jefferson University Hospitals.
Work at Kite Pharma
Sara Beygi serves as the Medical Director of Clinical Development at Kite Pharma. She has been in this role since 2021, contributing to the company's focus on innovative cancer therapies. Kite Pharma is known for its work in cell therapy, particularly in the development of CAR T-cell therapies. Beygi's expertise in clinical development plays a crucial role in advancing Kite's research initiatives and clinical trials.
Education and Expertise
Sara Beygi earned her Doctor of Medicine (MD) degree from Tehran University of Medical Sciences, completing her studies from 2005 to 2013. This rigorous medical education laid the foundation for her subsequent specialization in hematology and oncology. Her academic background supports her clinical development work, particularly in the field of cancer treatment.
Background
Before her current position at Kite Pharma, Sara Beygi completed a fellowship in Hematology/Oncology at Stanford University from 2018 to 2021. This three-year fellowship provided her with advanced training in the diagnosis and treatment of blood disorders and cancers. Prior to her fellowship, she worked as a Postdoctoral Researcher at Thomas Jefferson University Hospitals from 2013 to 2015 and completed her residency in Internal Medicine at Allegheny Health Network from 2015 to 2018.
Professional Experience
Sara Beygi has a diverse professional background in medicine and research. After her medical degree, she served as a Postdoctoral Researcher at Thomas Jefferson University Hospitals for two years, focusing on research in the medical field. Following this, she completed a three-year residency in Internal Medicine at Allegheny Health Network, where she gained extensive clinical experience before transitioning to her fellowship in Hematology/Oncology at Stanford University.